Is UHS stock a buy?

Is UHS stock a buy?

The 16 analysts offering 12-month price forecasts for Universal Health Services Inc have a median target of 132.50, with a high estimate of 160.00 and a low estimate of 118.00. The median estimate represents a +6.59% increase from the last price of 124.31.

Does UHS pay a dividend?

UHS pays a dividend of $0.80 per share. UHS’s annual dividend yield is 0.64%. UNIVERSAL HEALTH SERVICES’s dividend is lower than the US industry average of 1.78%, and it is lower than the US market average of 3.46%.

Is Sage Therapeutics a good buy?

Sage Therapeutics has received a consensus rating of Hold. The company’s average rating score is 2.35, and is based on 6 buy ratings, 11 hold ratings, and no sell ratings.

Are healthcare stocks good to buy now?

After lagging behind the market in 2021, health care stocks have outperformed the S&P 500 so far in 2022. Some health care stocks are still experiencing tail winds from the pandemic, while others are benefiting from a rebound in elective procedures.

Is UHS a Fortune 500 company?

About Universal Health Services, Inc. In 2020, UHS was again recognized as one of the World’s Most Admired Companies by Fortune; ranked #281 on the Fortune 500; and in 2017, listed #275 in Forbes inaugural ranking of America’s Top 500 Public Companies.

Who bought UHS?

Universal Health Services, Inc. (NYSE: UHS) is pleased to announce that it has entered into a binding agreement for a strategic alignment with Riverside Medical Clinic (RMC) located in Riverside County, California.

Does United Rentals pay a dividend?

UNITED RENTALS (NYSE: URI) does not pay a dividend.

Has Afterpay paid a dividend?

There is no dividend history for Afterpay Limited.

Will SAGE stock go back up?

The 21 analysts offering 12-month price forecasts for SAGE Therapeutics Inc have a median target of 54.00, with a high estimate of 105.00 and a low estimate of 36.00. The median estimate represents a +43.92% increase from the last price of 37.52.

Is SAGE a buy or sell?

Out of 14 analysts, 2 (14.29%) are recommending SAGE as a Strong Buy, 2 (14.29%) are recommending SAGE as a Buy, 10 (71.43%) are recommending SAGE as a Hold, 0 (0%) are recommending SAGE as a Sell, and 0 (0%) are recommending SAGE as a Strong Sell. What is SAGE’s earnings growth forecast for 2022-2024?

Which medical stock is best?